实用皮肤病学杂志2024,Vol.17Issue(2) :93-96,106.DOI:10.11786/sypfbxzz.1674-1293.20240208

药物超敏反应综合征发病及预后的相关进展

Advances in the pathogenesis and prognosis of drug-induced hypersensitivity syndrome

曹嘉力 邢昕竹 范洁 何焱玲
实用皮肤病学杂志2024,Vol.17Issue(2) :93-96,106.DOI:10.11786/sypfbxzz.1674-1293.20240208

药物超敏反应综合征发病及预后的相关进展

Advances in the pathogenesis and prognosis of drug-induced hypersensitivity syndrome

曹嘉力 1邢昕竹 1范洁 2何焱玲1
扫码查看

作者信息

  • 1. 100020 北京,首都医科大学附属北京朝阳医院皮肤科
  • 2. 北京市顺义区妇幼保健院医务科
  • 折叠

摘要

药物超敏反应综合征(DIHS)又称为伴嗜酸粒细胞增多和系统症状的药疹,是一种特殊类型的重症药疹.临床表现以皮损、发热、淋巴结增大、血液学异常及多脏器受损为主,同时可伴有人疱疹病毒6(HHV-6)的重新激活.目前认为DIHS的发病机制是疱疹病毒和机体免疫反应之间复杂相互作用的结果,并与个体基因易感性等因素有关,趋化因子在发病过程中也起到重要作用.兹对DIHS发病机制及临床治疗、预后的相关进展进行综述.

Abstract

TDrug-induced hypersensitivity syndrome(DIHS),which is also called drug eruption with eosinophilia and systemic symptoms(DRESS),is one of the most severe adverse drug reactions.DIHS clinically presents as an extensive cutaneous rash with fever and lymphadenopathy,hematologic abnormalities and multiple organ involvement.In addition,It's usually accompanied with the re-activation of human herpesvirus-6(HHV-6)virus.Pathogenesis of DIHS has been linked to HHV-6 reactivation and immune reaction,and also related to genetic susceptibility.Chemokines play an important role in the progress.This review summarizes the progress in pathogenesis and prognosis of DIHS.

关键词

药物超敏反应综合征/基因/趋化因子/治疗/预后

Key words

Drug-induced hypersensitivity syndrome/Gene/Chemokines/Treatment/Prognosis

引用本文复制引用

出版年

2024
实用皮肤病学杂志
中国人民解放军北京军区总医院

实用皮肤病学杂志

CSTPCD
影响因子:0.637
ISSN:1674-1293
段落导航相关论文